(S)-4-phenyl-1-(2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl)butan-1-one

ID: ALA1096860

Chembl Id: CHEMBL1096860

PubChem CID: 46889308

Max Phase: Preclinical

Molecular Formula: C19H28N2O

Molecular Weight: 300.45

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CCCc1ccccc1)N1CCC[C@H]1CN1CCCC1

Standard InChI:  InChI=1S/C19H28N2O/c22-19(12-6-10-17-8-2-1-3-9-17)21-15-7-11-18(21)16-20-13-4-5-14-20/h1-3,8-9,18H,4-7,10-16H2/t18-/m0/s1

Standard InChI Key:  ASBRDHZSNAUNHP-SFHVURJKSA-N

Associated Targets(non-human)

PREP Prolyl endopeptidase (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 300.45Molecular Weight (Monoisotopic): 300.2202AlogP: 3.10#Rotatable Bonds: 6
Polar Surface Area: 23.55Molecular Species: BASEHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.11CX LogP: 3.03CX LogD: 1.32
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.81Np Likeness Score: -0.99

References

1. Lawandi J, Gerber-Lemaire S, Juillerat-Jeanneret L, Moitessier N..  (2010)  Inhibitors of prolyl oligopeptidases for the therapy of human diseases: defining diseases and inhibitors.,  53  (9): [PMID:20058865] [10.1021/jm901104g]

Source